ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2137

Clinical Factors Associated with Long-Term Damage and Calcinosis in an Adult-Age Referral Population of Juvenile Myositis Patients

Vladislav Tsaltskan1, Annette Aldous2, Sam Serafi1, Heidi Sami1, Gulnara Mamyrova1, Frederick W Miller3, Sam Simmens2, Rodolfo Curiel1, Olcay Y. Jones4 and Lisa G Rider3, 1Department of Rheumatology, George Washington University, Washington, DC, 2Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC, 3Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, 4Department of Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: calcinosis, juvenile dermatomyositis, Myositis, outcomes and prognostic factors

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Juvenile idiopathic inflammatory myopathies (JIIM) are rare, autoimmune chronic muscle diseases of childhood with significant potential long-term morbidity. In this study we investigate associations of clinical and demographic factors with long-term outcomes in a referral population of patients with JIIM who are currently adults.

Methods: Adults with JIIM were assessed at two referral centers between 1994 and 2016. Bivariate analysis was used to test for associations of 94 clinical, demographic, and laboratory factors with two long-term outcomes: a higher Myositis Damage Index (MDI) and the presence of calcinosis on last evaluation. A multivariable regression model for MDI used backwards selection on factors with statistically significant associations (p < .15) in bivariate analysis.

Results:  Forty-nine patients with probable or definite JIIM (37 dermatomyositis, 5 polymyositis, 7 overlapping myositis) had a median age of 24 years [IQR 19, 28], and median follow-up period of 12 years after diagnosis [IQR 5, 20]; 59% were Caucasian and 82% were female; 63% had a chronic, 31% a polycyclic, and 6% a monocyclic illness course. Damage was present in 96%, with a median MDI score of 6 [IQR 3, 9]. Cutaneous (80%) and muscle (78%) damage were most frequent and most severe (median score 2 [IQR 1, 3] for both) among the MDI organ systems. Calcinosis was present in 55% of patients. Of the 94 potential predictors, 17 were significantly (p < 0.15) associated with total MDI score and 11 were significantly (p < 0.05) associated with the presence of calcinosis (Table). All selected variables in the multivariable model were independently associated with a higher MDI score: erythroderma, shawl sign, disease duration, worst ACR functional class, and heliotrope rash. Several factors were strongly associated with calcinosis in bivariate analysis including disease duration, younger age at diagnosis, falling episodes, Gottron’s papules, clinical subgroup JDM, constipation, periungual capillary changes, lipodystrophy, and contractures (Table). The multivariable logistic regression model for calcinosis did not converge due to the small sample size.

Conclusion:  This is one of the largest cohorts of patients with JIIM evaluated for long-term outcomes into adulthood. We were able to identify multiple clinical factors associated with long-term damage and calcinosis when JIIM patients become of adult age, which included specific cutaneous and musculoskeletal features.    


Disclosure: V. Tsaltskan, None; A. Aldous, None; S. Serafi, None; H. Sami, None; G. Mamyrova, Cure JM, 2; F. W. Miller, None; S. Simmens, None; R. Curiel, Cure JM, 2,BMS, 2; O. Y. Jones, None; L. G. Rider, None.

To cite this abstract in AMA style:

Tsaltskan V, Aldous A, Serafi S, Sami H, Mamyrova G, Miller FW, Simmens S, Curiel R, Jones OY, Rider LG. Clinical Factors Associated with Long-Term Damage and Calcinosis in an Adult-Age Referral Population of Juvenile Myositis Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/clinical-factors-associated-with-long-term-damage-and-calcinosis-in-an-adult-age-referral-population-of-juvenile-myositis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-factors-associated-with-long-term-damage-and-calcinosis-in-an-adult-age-referral-population-of-juvenile-myositis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology